Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: £1.35 M
• Last 3 months FTD volume: £6.38 M
• Last year FTD volume: £6.38 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	£7.68 M	£0.12 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£1.7 M	£23.6 M	🇺🇸 USA
Neurocrine Biosciences NBIX	£7.92 M	£16.82 M	🇺🇸 USA
General Electric GE	£0.28 B	£1.23 B	🇺🇸 USA
Thermo Fisher Scientific TMO	£18.45 M	£0.14 B	🇺🇸 USA
Bristol-Myers Squibb BMY	£0.18 B	£0.50 B	🇺🇸 USA
Pfizer PFE	£32.79 M	£0.34 B	🇺🇸 USA
Bio-Techne TECH	£0.56 M	£17.99 M	🇺🇸 USA
Sangamo Therapeutics SGMO	£1.06 M	£6.39 M	🇺🇸 USA
Charles River Laboratories CRL	£9.64 M	£51.1 M	🇺🇸 USA